This mechanism is well illustrated by several engineered peptides, as demonstrated by the tumor-homing peptide iRGD which initially binds αV integrins through its RGD motif before proteolytic cleavage unveils its C-terminal CendR motif, thereby facilitating NRP-1-dependent tissue penetration [41]. The gene discussed is NRP1; the disease is neoplasm.